← Back to Search

Gamified Feedback for Adolescent Alcohol Use (GANDR Trial)

Phase 2

Recruiting

Research Sponsored by Loyola Marymount University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

To play CampusGANDR, individuals must be at least 18 years of age and currently enrolled as an incoming first-year student at one of the two study sites

To take part in the evaluation study, participants must be a CampusGANDR user between 18 and 20 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, 12 months

Awards & highlights

GANDR Trial Summary

This trial looks at a new app that aims to reduce college students' alcohol use by delivering feedback about their peers' attitudes and behaviors towards alcohol as part of a game. Early studies suggest that it may be more effective than standard approaches, especially among heavier-drinking students and those who see more alcohol-related content on social media.

Who is the study for?

This trial is for incoming first-year college students aged 18-20 who have a smartphone or computer with internet. They must be willing to accept the app's terms and participate in the study by providing informed consent.Check my eligibility

What is being tested?

The trial tests CampusGANDR, an app that uses games to give feedback on alcohol use perceptions among peers. It aims to correct misconceptions and reduce drinking, especially in heavy drinkers and those influenced by social media.See study design

What are the potential side effects?

Since this intervention involves a gamified app rather than medication, traditional side effects are not expected. However, participants may experience changes in their drinking habits or perceptions about peer alcohol use.

GANDR Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 or older and a new student at one of the study sites.

Select...

I am between 18 and 20 years old and use CampusGANDR.

GANDR Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, 12 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, 12 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change from Baseline Alcohol Consequences at 12 Months

Change from Baseline Alcohol Consequences at 4 Months

Change from Baseline Alcohol Consequences at 9 Months

+6 more

Secondary outcome measures

Change from Baseline Descriptive Peer Drinking Norms- Drinking Norms Rating Form at 12 Months

Change from Baseline Descriptive Peer Drinking Norms- Drinking Norms Rating Form at 4 Months

Change from Baseline Descriptive Peer Drinking Norms- Drinking Norms Rating Form at 9 Months

+6 more

Other outcome measures

CampusGANDR number of student sign-ups per cohort per site

average number of CampusGANDR rounds played per non-RCT user

GANDR Trial Design

3Treatment groups

Active Control

Placebo Group

Group I: Light Dose of Alcohol PNFActive Control1 Intervention

Personalized Normative Feedback on Alcohol Use delivered in 33% of weekly rounds

Group II: Heavy Dose of Alcohol PNFActive Control1 Intervention

Personalized Normative Feedback on Alcohol Use delivered in 67% of weekly rounds

Group III: Control PNFPlacebo Group1 Intervention

Personalized Normative Feedback on non-alcohol/health related topics delivered in all weekly rounds (active control)

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of HoustonOTHER

147 Previous Clinical Trials

45,682 Total Patients Enrolled

6 Trials studying Alcoholism

1,348 Patients Enrolled for Alcoholism

Loyola Marymount UniversityLead Sponsor

5 Previous Clinical Trials

4,265 Total Patients Enrolled

3 Trials studying Alcoholism

1,966 Patients Enrolled for Alcoholism

Media Library

Light Dose of Alcohol PNF Clinical Trial Eligibility Overview. Trial Name: NCT04356261 — Phase 2

Alcoholism Research Study Groups: Control PNF, Light Dose of Alcohol PNF, Heavy Dose of Alcohol PNF

Alcoholism Clinical Trial 2023: Light Dose of Alcohol PNF Highlights & Side Effects. Trial Name: NCT04356261 — Phase 2

Light Dose of Alcohol PNF 2023 Treatment Timeline for Medical Study. Trial Name: NCT04356261 — Phase 2

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What are the primary aims of this medical research endeavor?

"The primary measure of success for this trial, which will take place within a 4 month time frame, is to monitor changes in daily drinking habits. Secondary outcomes include assessing the modified quantity and frequency of peer drinking norms over 9 months as well as rating form assessments at 12 months."

Answered by AI

Are there currently any opportunities to enroll in this scientific exploration?

"Per the information noted on clinicaltrials.gov, this medical study is presently recruiting participants. The initial posting of the trial was made in mid-August 2021 and it has been up to date as recent as April 2022."

Answered by AI

Does this trial allow for the enrollment of geriatric patients?

"The upper limit of this medical trial is 20 years old, and the lower bound being 18. Furthermore, there are 24 trials for minors and 206 for elderly individuals regarding this particular medication or intervention."

Answered by AI

What is the scope of participation for this clinical experiment?

"Affirmative. According to clinicaltrials.gov, the trial which was initially published on August 15th 2021 is currently in the process of selecting participants. The study needs 1800 people from one location for enrollment."

Answered by AI

How hazardous is the Heavy Dose of Alcohol PNF protocol to recipients?

"As this is only a Phase 2 trial, meaning there's some evidence of safety but not yet efficacy, the risk profile for Heavy Dose Alcohol PNF was given a rating of 2."

Answered by AI

Am I eligible to participate in this clinical research?

"This investigation seeks to recruit 1800 adolescents with a history of underage drinking, aged 18-20. To qualify for the trial, applicants must possess either a smartphone or device connected to the internet that can access the app, be enrolled as an incoming student at one of two study sites, accept CampusGANDR Terms and Privacy Policy's, answer screening questions and meet additional RCT inclusion criteria before formally consenting their involvement in this evaluation."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Revolutionizing Normative Re-education

2021. "Revolutionizing Normative Re-education". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04356261.

All > Alcoholism